Followers | 1316 |
Posts | 26937 |
Boards Moderated | 6 |
Alias Born | 12/10/2012 |
Friday, September 03, 2021 12:18:02 PM
Lets get yesterday $12 in PREMARKET again.
how awesome would that really be right ??
GO $IPHA
Recent IPHA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/08/2024 11:00:41 AM
- Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024 • Business Wire • 11/08/2024 06:00:00 AM
- Innate Pharma annonce les présentations de données de son portefeuille innovant en oncologie sélectionnées pour le congrès annuel du SITC 2024 • Business Wire • 11/08/2024 06:00:00 AM
- Innate Pharma organise une conférence téléphonique pour ses résultats financiers et l’avancée de son portefeuille au troisième trimestre 2024 • Business Wire • 11/07/2024 06:00:00 AM
- Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates • Business Wire • 11/07/2024 06:00:00 AM
- Innate Pharma annonce sa participation à de prochaines conférences investisseurs • Business Wire • 10/29/2024 06:00:00 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conferences • Business Wire • 10/29/2024 06:00:00 AM
- Jonathan Dickinson est nommé Président du Directoire d’Innate Pharma • Business Wire • 10/14/2024 05:00:00 AM
- Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board • Business Wire • 10/14/2024 05:00:00 AM
- Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024 • Business Wire • 09/30/2024 05:00:00 AM
- Innate Pharma co-organise un symposium scientifique en présence d’experts de l’Immunotherapie à New York le 3 octobre 2024 • Business Wire • 09/30/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 10:03:48 AM
- Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors • Business Wire • 09/23/2024 05:00:00 AM
- Innate Pharma reçoit l’autorisation de l’agence américaine du médicament d’initier le développement clinique d’IPH4502, son ADC ciblant Nectine-4, dans les tumeurs solides • Business Wire • 09/23/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 10:15:07 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 10:07:46 AM
- U.S. Index Futures Climb Ahead of Key Economic Data Releases; Oil Prices Rise • IH Market News • 09/12/2024 10:04:12 AM
- Innate Pharma Reports First Half 2024 Business Update and Financial Results • Business Wire • 09/12/2024 05:00:00 AM
- Innate Pharma présente l’avancée de son portefeuille et ses résultats financiers au premier semestre 2024 • Business Wire • 09/12/2024 05:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/11/2024 08:00:52 PM
- Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Innate Pharma SA: Présentation de données de monalizumab issues de l’étude de Phase 2 NeoCOAST-2 dans le cancer du poumon non à petites cellules au stade précoce à la conférence mondiale sur le cancer du poumon 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Innate Pharma organise une conférence téléphonique pour présenter ses résultats financiers et l’avancée de son portefeuille au premier semestre 2024 • Business Wire • 09/05/2024 05:00:00 AM
- Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update • Business Wire • 09/05/2024 05:00:00 AM
- Innate Pharma annonce sa participation à la 26ème Annual Global Investment Conference de H.C. Wainwright • Business Wire • 09/04/2024 05:00:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM